Cargando…
Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure
Direct oral anticoagulants (DOACs) are at least as efficacious and safe as warfarin among non-valvular atrial fibrillation (NVAF) patients; limited evidence is available regarding NVAF patients with heart failure (HF). US Medicare enrollees with NVAF and HF initiating DOACs (apixaban, rivaroxaban, d...
Autores principales: | Amin, Alpesh, Garcia Reeves, Alessandra B., Li, Xiaoyan, Dhamane, Amol, Luo, Xuemei, Di Fusco, Manuela, Nadkarni, Anagha, Friend, Keith, Rosenblatt, Lisa, Mardekian, Jack, Pan, Xianying, Yuce, Huseyin, Keshishian, Allison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433218/ https://www.ncbi.nlm.nih.gov/pubmed/30908512 http://dx.doi.org/10.1371/journal.pone.0213614 |
Ejemplares similares
-
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population
por: Amin, Alpesh, et al.
Publicado: (2019) -
Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
por: Deitelzweig, Steven, et al.
Publicado: (2019) -
Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients
por: Deitelzweig, Steven, et al.
Publicado: (2021) -
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity
por: Dhamane, Amol D., et al.
Publicado: (2022) -
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
por: Dhamane, Amol D, et al.
Publicado: (2021)